Will Tirzepatide Finally Turn the Tide in Access to Obesity Treatment?

Now that tirzepatide has been approved for weight loss, and renamed “Zepbound,” doctors have another tool to treat excess weight. But will high costs and a lack of coverage prevent patients from getting it?

Read more at HCP Live